New York § 2019 Duties of the commissioner

New York Statutes

§ 2019 — Duties of the commissioner

New York § 2019

Law PBHPublic Health

Art. 20-CState Frontotemporal Degeneration Registry

This text of New York § 2019 (Duties of the commissioner) is published on Counsel Stack Legal Research, covering New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

N.Y. Public Health § 2019 (2026).

Text

  § 2019. Duties of the commissioner. The commissioner may promulgate\nany regulations necessary to implement the provisions of this article,\nincluding but not limited to:\n  1. establishing the form, content, and manner by which providers shall\nreport FTD disorders information into the registry established under\nsection two thousand seventeen of this article;\n  2. prescribing the permissible uses for the information made available\nunder this article; and\n  3. establishing procedures to maintain the confidentiality of\ninformation collected by providers and provided to members of the\ndepartment pursuant to this article. This shall include a procedure to\nensure that confidential patient information is deidentified prior to\nbeing provided to authorized participants under this articl

Free access — add to your briefcase to read the full text and ask questions with AI

§ 2019. Duties of the commissioner. The commissioner may promulgate\nany regulations necessary to implement the provisions of this article,\nincluding but not limited to:\n 1. establishing the form, content, and manner by which providers shall\nreport FTD disorders information into the registry established under\nsection two thousand seventeen of this article;\n 2. prescribing the permissible uses for the information made available\nunder this article; and\n 3. establishing procedures to maintain the confidentiality of\ninformation collected by providers and provided to members of the\ndepartment pursuant to this article. This shall include a procedure to\nensure that confidential patient information is deidentified prior to\nbeing provided to authorized participants under this article.\n